Mark S. Chesnutt, M.D.
- Pulmonary Medicine
- Special Interest:
- Critical Care
- Accepting Patients:
Dr. Chesnutt's clinical area of focus at OHSU is heredity hemorrhagic telangiectasia (HHT) and pulmonary arteriovenous fistula. He is Director of the OHSU Dotter Interventional Institute's Hereditary Hemorrhagic Telangiectasia Center of Excellence.
M.D., Oregon Health & Science University, Portland, OR, USA, 1986
Internal Medicine-University of California, San Francisco, 1986-1990
Pulmonary and Critical Care Medicine-University of California, San Francisco, 1992-1996
Internal Medicine, 1989 Pulmonary Diseases, 1994, 2004 Critical Care Medicine, 1998, 2008